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In this communication we explore the regulation of hapten-specific killing to both 
the trinitrophenol  (TNP)- and azobenzenearsonate  (ABA)-coupled  cells. We present 
evidence  indicating  that  Lyt-1 + T  cells are  required  for the  generation  of hapten- 
specific CTL. This helper T cell requirement can be replaced by some factor(s) present 
in the supernatant of rat spleen cells stimulated with Con A (Con A-Sup). In addition, 
the  generation  of hapten-specific  killing  is susceptible  to  tolerization.  At  least  two 
distinct  mechanisms  of  unresponsiveness  appear  to  be  operative.  Regulation  by 
antigen-specific Tsl cells appears to function at the level of helper T cell. Furthermore, 
a second nontransferable state of unresponsiveness is found. The significance of these 
findings will be discussed in terms of cellular regulation of generation of CTL in mice. 
Materials and Methods 
Mice.  A/J (H-2"), BALB/c (H-2  d) mice were obtained from The Jackson  Laboratory,  Bar 
Harbor,  ME.  All  the  animals  used  in  this  study  were  maintained  in  accordance  with  the 
guidelines of the Committee on Animals of the Harvard Medical School and those prepared by 
the Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Animal 
Resources, National Research Council (DHEW publication  [NIH]  78-23, revised  1978). 
Preparation of Antigen and Antigen-coupled Cells.  The ABA coupling of spleen cells has  been 
described in detail elsewhere (1). TNP-conjugated spleen cells were prepared as described (2). 
Induction of Immunological Unresponsiveness and Suppressor T Cells 
INDUCTION OF  IMMUNOLOGICAL UNRESPONSIVENESS.  To induce unresponsiveness,  mice were 
injected  intravenously  with  5  ×  107  ABA-SC  or  TNP-SC.  7  d  before  priming,  mice  were 
injected with 3 X  107 ABA-SC subcutaneously. 
ASSAY  OF  SUPPRESSOR T  CELLS.  5  X  107  spleen  cells  from  mice  treated  as  above  were 
transferred  intravenously into another group of naive recipients that  were immunized subcu- 
taneously  with  3  X  107  ABC-SC or TNP-SC.  5-7  d  later,  their  spleens  were  removed  and 
restimulated in vitro with hapten-SC for the induction of CTL. 
In Vitro Culture.  The culture conditions used are described in detail elsewhere (1-3). Briefly, 
7 ×  106 spleen cells from primed animals were co-cultured with 6 ×  106 ABAr- or TNP-coupled 
x-irradiated  (1,400 rad) spleen cells in a  volume of 2 ml for 5 d. 
Chromium Release Assay.  Gytotoxicity was calculated  on  the basis of the formula:  percent 
specific release  =  (e -  c)/(Ft  -  c)  ×  100%,  where c  is the spontaneous  release obtained  by 
incubating target cells with normal spleen cells in the 4-h assay. Ft value was calculated by four 
freeze-thaw cycles. Spontaneous  release of tumor cells usually ranged  from 8-16%  in the 4-h 
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assay. The assays were performed in duplicate. All cultures were assayed on both modified and 
unmodified  targets,  and  the background  lysis on unmodified  targets  was  substrated.  All the 
experiments have been done at least three times, with comparable results. 
Rat Con A  Supernatant.  The preparation  of Con A-stimulated rat  spleen cell culture super- 
natant  has been described in detail (4).  Supernatants  used in this study were all from one lot, 
which gives 50% maximum cpm of the IL-2-dependent L2.2 cell line (4) at a  dilution of 1:50. 
Control supernatants  consist only of alpha-methyl  manoside in identical media.  All dilutions 
shown are final concentrations added at the beginning of culture. 
Serum  Treatment.  Monoclonal  anti-Ly-l.2  antibodies  were  used  at  1:200  and  were  kindly 
provided by Dr. F. W. Shen (Memorial Sloan-Kettering Cancer Institute, New York). 5 ×  10  v 
spleen cells were incubated  for 45  min at  room temperature  with  1 ml of diluted anti-Ly-l.2 
antibody,  washed  twice,  and  then  incubated  with  1 ml  of  1:7  dilution  of Low Tox  rabbit 
complement  (Accurate Chemical and Scientific Corp., Westbury,  NY) for 30 min at 37°(2. 
Results and Discussion 
In  our  previous  report,  we  found  that  in  vivo  priming  followed  by  in  vitro 
restimulation was required for generation of hapten-specific CTL and that adoptive 
transfer  of suppressor  T  cells  (Ts)  induced  by  intravenous  injection  of hapten- 
conjugated spleen cells (TNP-SC) can limit the in vivo priming of cytotoxic T  cells 
(3).  This requirement for in vivo priming has been suggested to be at  least in part 
necessary  for  the  activation  of a  helper  T  cell  subpopulation,  which  provides  a 
differentiation signal for the activation of cytotoxic T  cells (1, 5). 
To further investigate the role of helper T  cells in the generation of ABA-specific 
cytotoxic T  cells in vitro, we examined the effect of treating the responder cells with 
a  monoclonal anti  Ly-l.2  + antibody plus complement to eliminate Ly-l.2+-bearing 
helper T  cells. As shown in Table I, treatment of responder cells with anti  Ly~l.2  + 
antibodies plus complement completely abrogated their ability to generate CTL. 
To further clarify whether the elimination of ABA-specific CTL response by anti- 
Ly-l.2  +  plus  complement  treatment  is  due  to  the  removal  of helper  T  cells  or 
elimination of Ly-l,2,3  ÷ cytotoxic T  cell precursors (6), we investigated the effect of 
adding Con A-Sup in vitro. Our results shown in Table I clearly demonstrated that 
in vitro addition of Con A-Sup can restore the response of aLy-1.2  + plus complement- 
treated responder cells.  Thus,  the CTL is  not  appreciably altered by the aLy-l,2  + 
treatment, but requires a Ly-l.2  + cell that can be replaced by factors present in Con 
A-Sup. The mechanisms and the molecules in the Con A-Sup that are responsible for 
providing the necessary signals for the induction of CTL have not been addressed in 
our experiment. The molecule responsible for the helper activity might be IL-2, which 
is present in the Con A-Sup  (7), as purified IL-2 has been reported able to provide 
nonspecific helper signals required for the activation of CTL (8). Based on the above 
experiments, we investigated the mode of action of hapten-specific Ts.  Because two 
cellular components are required for the generation of effector CTL, Ts might work 
either by inhibiting the helper T  cell or by limiting the CTL. In addition, because we 
were unable to demonstrate any Ts activity in in vitro mixing experiments (unpub- 
lished results), we postulated that Ts are functioning only during in vivo priming. If 
the Ts works primarily at the level of helper T  cells, we would expect CTL precursors 
to be present in a  suppressed animal.  To address this issue, an exogenous source of 
helper signals was added to the in vitro restimulation of a suppressed culture. 
The result of such an experiment is shown in Table II. TNP-specific Ts induced in 
BALB/c mice when transferred into naive recipients will significantly inhibit the in 920  SY  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TAaLE  I 
Effect of Anti-L YT-1.2 plus Complement Treatment on the Generation of 
ABA-specific CTL 
Percent specific lysis:[: 
Responder cells*  Responder cell  In  vitro  addition 
treatment  of Con A-Sup  Effector-to-target  ratio 
80:1  27:1  9:1 
ABA-SC (s.c.)  C'  -  55  32  20 
ABA-SC (s.c.)  Anti-Ly-l.2 +  C'  -  0  0  0 
ABA-SC (s.c.)  Anti-Ly-l.2  +  C'  +  (1:5)  70  58  30 
ABA-SC (s.c.)  Anti-Ly-l.2  +  C'  +  (1:10)  60  59  42 
* Responder  cells  were  obtained  from the spleen  of A/J  mice that  were  injected  with  3  ×  l07 
ABA-SC subcutaneously  7  d  earlier.  7  million  responder  cells  were co-cultured  with  6  ×  106 
ABA-SC (A/J)  for 5 d. 
:~ After 5 d, cytolytic activity was assayed on ABA-modified P815 tumor cells. In this experiment 
spontaneous  release was  16.6%. 
TABLE II 
Reversal of TNP Suppressor T Cell Activity by In  Vitro Addition of Con A Supernatants 
Pretreatment  of responder cell donors* 
Percent specific lysis, 
In vitro addition of Con A  effector/ 
supernatants  target ratio~: 
100:1  33:1  11:1 
(A)  TNP-SC (s.c.)  --  64.2  66.2  58.4 
(B)  TNP-SC (s.c.)  +  5  ×  107 Ts~  40.2  28.1  20.2 
(C)  TNP-SC (s.c.)  +  5  ×  107 Tsl  +  (1:10)  64.3  65.5  62.6 
(D)  TNP-SC (s.c.)  +  5  ×  107 Tsl  +  (1:30)  61.5  31.5  48.7 
(E)  TNP-SC (s.c.)  +  5  X  107 Ts~  Control  supernatants  38.6  31.5  19.7 
80:1  26:1  9:1 
(A)  ABA-SC (s.c.)  --  54  33.5  18.3 
(B)  ABA-SC (s.c.)  +  5  ×  107 Tsl  26  11.5  3.0 
(C)  ABA-SC (s.c.)  +  5  ×  107 Ts~  +  (1:10)  69  49.4  20.8 
(D)  ABA-SC (s.c.)  +  5  ×  107 Ts~  Control supernatants  24  13.0  4.0 
* Responder cell donors were either immunized with 3 ×  107 antigen-coupled spleen cells (s.c.)  with or without concomitant 
5 ×  107 suppressor T  cells (i.v.), as described in Materials and Methods. 
:~ Cytolytic  activity was assayed on TNP-modified  P815  cells  in the TNP  experiment  or on  ABA-modified  P815  in the 
ABA experiment.  Spontaneous  release in the TNP was 12.9% and in the ABA,  16.6%. 
vivo priming of TNP-specific CTL  (compare  group  B  to  group  A).  Furthermore, 
addition  of Con  A-Sup  as  an  exogenous source of helper signals  in  vitro, but  not 
control supernatants, completely abrogated the Ts effect (groups C, D, and E). This 
CTL  activity  in  the  presence of Con  A-Sup  is  hapten  specific  (data  not  shown). 
Identical experiments were performed using another hapten  in  A/J  mice, and  the 
results  are  presented  in  the  lower  one-half of Table  II.  ABA-specific  Tsl,  when 
transferred into naive recipients, inhibits the in vivo priming of ABA-specific CTL. 
Similar to the observation in the TNP system, suppression in the ABA system can 
also be reversed by in vitro addition of Con A-Sup. These results, in some respects, 
mimic  the  aLy-l.2  +  plus  complement  experiment  (Table I)  and  thus  allow  us  to 
suggest that Ts might inhibit the generation of CTL by inhibiting the helper T  cells. 
Our results are consistent with the hypothesis that the Con A-Sup reversed suppression 
by providing a helper signal in the same way that it provides the necessary signal in 
the  aLy-l.2+-depleted cultures.  This observation  is  in  some respects similar  to the 
earlier findings of Butler et al.  (9).  The mechanisms whereby Ts regulates helper T SY  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE III 
Two Distinct Mechanisms Regulate the In  Vivo Induction of TNP-specific  Cytotoxic T Cells 
921 
Pretreatment of responder cell donors*  In vitro addition of Con A 
supematants 
Percent specific lysis 
effector-to-target ratio:~ 
Day --7  Day 0  90:1  30:1  10:1 
(A)  --  TNP-SC (s.c.)  --  79.8  77.5 
(B)  --  TNP-SC (s.c.) +  Tsl  --  2  0 
(C)  --  TNP-SC (s.c.)  +  Tst  +  (1:20)  48.2  20.4 
(D)  --  TNP-SC (s.c.)  +  Tsx  +  (1:30)  17.6  7 
(E)  --  TNP-SC  (s.c.)  +  Tsl  Control sopematants  0  1.4 
(F)  TNP-SC (i.v.)  TNP-SC (s.c.)  --  0  0 
(G)  TNP-SC (i.v.)  TNP-SC (s.c.)  +  (1:20)  0  0 
(H)  TNP-SC (i.v.)  TNP-SC  (s,c.)  +  (1:30)  2  0 
(I)  TNP-SC (i.v.)  TNP-SC (s,c.)  Control supernatants  0  0 
100:1  33:1 
(A)  --  ABA-SC (s.c.)  --  31  20.9 
(B)  --  ABA-SC (s.c.)  +  Tsl  --  0  3 
(C)  --  ABA-SC (s,c.)  +  Tsl  +(1:10)  35.2  15 
(D)  ABA-SC (i.v.)  ABA-SC (s,c.)  --  1  3 
(E)  ABA-SC (i.v.)  ABA-SC (s.c.)  +(l:10)  6.8  4 
58.5 
1 
9.1 
5 
0 
0 
0 
0 
0 
11:_..~1 
5.8 
l 
5.6 
5 
5 
* Responder cells were prepared as described in the text. 
~: Cytolytic  T  cell activity was assayed on  TNP-modified  P815  cells in  the TNP  experiment and  ABA-modified  YAC 
tumor cells in the ABA experiment. Spontaneous release:  TNP,  14%;  ABA 33%. 
cell activity have not been well defined. It has been suggested that Ts may inhibit the 
production of IL-2  or diminish  IL-2  activity,  either by competing  for the available 
IL-2  (10,  11)  or inactivating IL-2  (12,  13).  If Ts are working mainly by inactivating 
IL-2 or competing for the available IL-2, suppression should be demonstrable by in 
vitro mixing experiments. 
During the course of these studies, we noted that the mice serving as donors of Ts 
showed profound unresponsiveness when primed  and  restimulated  in  vitro.  In  this 
case, normal BALB/c mice were injected intravenously with 5 ×  107 TNP-SC on day 
-7.  On day 0, instead of using these animals as donors of Ts, some of these animals 
were sensitized with 3 ×  107 TNP-SC subcutaneously. 5 d later, their spleen cells were 
co-cultured in vitro with TNP-SC  as stimulator cells for another 5  d. The results of 
such an experiment  are shown in Table  III  (upper one-half).  Spleen cells obtained 
from BALB/c  mice that  had been injected  intravenously with TNP-SC  on day  -7 
and then sensitized subcutaneously again on day 0, when restimulated  in vitro with 
TNP-SC,  were unable  to  mount  any significant  level  of CTL  activity.  This  result 
(group F) is similar to the inhibition of in vivo priming by Ts (group B). Interestingly, 
in vitro addition of Con A-Sup was unable to abolish the unresponsiveness observed 
in these cultures (group G and H). The identical Con A-Sup reversed the suppression 
seen in cultures containing responder cells obtained from recipients of Ts  (groups C 
and D). 
Similar  experiments  have also  been  done  in  the  ABA  system  in  A/J  mice.  The 
results are comparable to those obtained in the TNP system in BALB/c mice and are 
shown in the lower one-half of Table III. Thus, we identified two unresponsive states 
in a hapten-specific CTL system that differ in their ability to be reconstituted by Con 
A-Sup.  The exact  mechanisms that  determine why the unresponsiveness, cannot be 
overcome in tolerized mice in contrast to suppressed mice, by in vitro addition of Con 
A-Sup,  are not clear.  One trivial  explanation  is that  there are simply  more Ts  in a 
nontransfer  situation.  Thus,  more  Con  A-Sup  might  be  required  for  reversal  of 
unresponsiveness  to  occur.  However,  this  appears  unlikely  because  even  when  we 922  sY ET AL.  BRIEF  DEFINITIVE REPORT 
added a  three times higher concentration  of Con A-stimulated culture supernatant, 
no significant increase in CTL activity was observed. Another possibility is that there 
are additional  subpopulations of Ts in  the tolerized  animals that  work directly on 
CTL or their precursors and, thus, result in a  nonreversible defect. In addition,  it is 
possible that intravenous injection of hapten-conjugated spleen cells not only induces 
Ts,  but  also results  in  a  direct  blockade of CTL precursors.  A  dual  mechanism of 
immunological unresponsiveness involving both Ts and receptor blockade has been 
shown to exist in the regulation of contact sensitivity to DNFB in mice (14). 
It  is  not  known  why  unresponsiveness  induced  by water-soluble  TNBS  can  be 
reversed by Con A-Sup (9), whereas unresponsiveness induced by TNP-SC failed to 
do so.  However, it  has been shown  (14)  in  the regulation  of the contact  sensitivity 
system that intravenous injection of DNBS and DNP-SC represents two very different 
tolerogenie regimens. In addition, reports from other laboratories (15-17) were unable 
to induce immunologic tolerance in vivo using TNP-SC, but the experimental protocol 
these investigators used is quite different from ours. In our experimental design, after 
intravenous  tolerization,  there  is  an  additional  in  vivo  priming  before  in  vitro 
restimulation. 
The inability of Con A-Sup to reverse unresponsiveness has certain  implications 
concerning the mechanism of activation of CTL. It has been proposed recently  (5) 
that two helper T  cells might be required for the activation of CTL. Unprimed CTL 
precursors in vivo might require a differentiation signal from one helper T  cell and a 
proliferation signal  (probably mediated by IL-2) from a  second set of helper T  cells 
in the presence of antigen to generate CTL. In the absence of the first signal, unprimed 
CTL precursors were unable to accept the IL-2 signal. Therefore, it is possible that 
intravenous  injection  of hapten-conjugated  spleen  cells  might  have inactivated  the 
first helper T  cell that is required for the delivery of the first signal and, thus, resulted 
in the failure to generate any CTL even in the presence of exogenous helper signals. 
On  the other hand,  suppressor T  cells,  when  adoptively transferred  to a  recipient, 
might allow the activation of the first helper T  cells but inhibit the activity of second 
set of helper T  cells. Experiments are now in progress to address these issues. 
Summary 
Treatment of responder cells with monoclonal anti-Ly- 1,2 antibodies plus comple- 
ment  in  vitro  completely eliminated  their  ability  to  generate  azobenzenearsonate 
(ABA)-specific cytolytic T lymphocytes (CTL). However, addition of the concanavalin 
A-stimulated supernatants of rat spleen cells (Con A-Sup)  can fully reconstitute the 
response. Therefore, Lyt- 1,2-bearing T  cells are required  for the generation of ABA- 
specific CTL, and such requirement can be replaced by factors present in the Con A- 
Sup.  Suppressor T  cells (Ts), when adoptively transferred into naive recipients, will 
inhibit  the in vivo priming of CTL. This inhibition  can also be reversed by in vitro 
addition of Con A-Sup. Furthermore, mice serving as donors of Ts also show profound 
unresponsiveness  when  primed  and  restimulated  in  vitro.  In  contrast  to  the  Ts- 
mediated  inhibition,  in  vitro  addition  of Con  A-Sup  was  unable  to  abolish  the 
unresponsiveness  observed  in  these  cultures.  Thus,  we  identified  two  unresponsive 
states in a hapten-specific killing system that differ in their ability to be reconstituted 
by Con A-Sup. 
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